GOC Position Statement - Intraperitoneal Chemotherapy for Ovarian Cancer

GOC Position Statement - Prophylactic HPV Vaccines

GOC Position on NACI Statement on Human Papillomavirus Vaccine

GOC Position Statement Regarding Ovarian Cancer Screening

GOC Statement regarding CA125 Monitoring in the Management of Recurrent Ovarian Cancer

GOC Position Statement Regarding the Resignation of Three Gynecologic Oncologists in Newfoundland and Labrador

GOC Statement Regarding: Regarding: BC’s Gynecologists change surgical method to protect against

GOC Summary Statement on Current Status of Ovarian Cancer Screening with Ca125 and Transvaginal Ultrasound in Women Aged 55-74

GOC Position Statement of Cervical Cancer Vaccines

GOC Statement Regarding Salpintectomy and Ovarian Cancer Prevention

GOC Position Statement Regarding Ovarian Cancer Screening

GOC Position Statement Regarding Ovarian Cancer Screening (April 2009, PDF)

A founding partner of CG²